Altered zinc levels in prostate benign prostatic hyperplasia (BPH) and carcinoma is well documented. It is not known whether loss of zinc, necessary to restrain aggressive growth, results from loss of a single specific or multiple zinc transporters.
Department of Internal Medicine, Division of Hematology/Oncology and Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. fwbeck@med.wayne.edu